Annals of the Rheumatic Diseases
Impact Factor Trend (2018–2026)
Clarivate IF trend for Annals of the Rheumatic Diseases
SCImago Journal Rank citation prestige weighting
315 papers with at least that number of citations each
Aims & Scope
Annals of the Rheumatic Diseases (ARD) is an international peer review journal committed to promoting the highest standards of scientific exchange and education. It covers all aspects of rheumatology, which includes the spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research. Concise scientific communication is encouraged and peer reviewed proceedings of international meetings are featured. Educational papers include state of the art reviews, "how to" articles and educational cases that focus on problems faced in clinical practice. The journal was first published in 1939 and has an authorative global Editorial Board and a growing international readership.
Special Issues
Calls for PapersNo active Calls for Papers found for this journal.
WoS Categories & Quartiles
Detailed JCR / JCI category rankings and quartile breakdown from Clarivate
RHEUMATOLOGY
RHEUMATOLOGY
Annual Historical Statistics & Publications
Track annual publication volume, total citations, and Impact Factor evolution
SCImago & Scopus Journal Intelligence
Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact
Weighted prestige citation metric per document indexed in the Scopus database.
Average citations received per document published in the 2-year window.
Estimated Article Processing Charge for Open Access publication.
Scopus 3-Year Publication & Citation Window
Aggregated from Scopus database across the 3-year SJR evaluation window.
Societal Impact & Inclusivity (SCImago)
Citations in government and international policy documents
Percentage of female authors published in the journal
Real-world societal policy reach and author gender diversity tracked by SCImago.
Scopus Subject Categories
Journal Metrics & Citation Visualizations
Total Cites vs Self-Cites
Evaluation of scholarly independence and citation reach
Citations per Document
Citation metric windows across 2, 3, and 4 years
Chinese Academy of Sciences (CAS) Classification
Major / minor zone classification and CAS Early Warning List history
Academic Intelligence Overview & Context
ImpaQ AnalysisAnnals of the Rheumatic Diseases (acronym: ard, abbr: ANN RHEUM DIS, ISSN: 0003-4967) is a peer-reviewed international scholarly journal in the field of Medicine, published by BMJ Publishing Group in England since 1939. The periodical holds a Journal Impact Factor (JIF) of 24.0, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 7.286 (Q1), an H-index of 315.
The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 246 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $4,661 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.
Publishing & Editorial Information
Detailed publisher, peer-review turnaround, and publication cycle specifications
Similar Journals in Discipline
Journals in the same research field with comparable impact metrics